title: Comparison of the influence of nonpreserved oxybuprocaine and a preserved artificial tear (thera tears) on human corneal thickness measured by two pachymeters.
abstract: OBJECTIVE
  To compare the effect of nonpreserved oxybuprocaine and preserved artificial tears on central corneal thickness (CCT) obtained by 2 pachymeters.
  
  
  METHODS
  In this prospective, placebo-controlled study, involving a random sample of 100 eyes of 50 subjects, aged 24±2.3 years, CCT readings were obtained in 2 separate sessions with the Topcon SP-3000P and ultrasound pachymetry (USP), respectively, before, 5 and 10 min after instillation of a drop each of either oxybuprocaine hydrochloride (oxybuprocaine HCl) (group 1) or carboxymethylcellulose sodium, thera tears (group 2), and placebo.
  
  
  RESULTS
  The baseline mean CCT for SP-3000P was 509±38 μm and 542±36 μm for USP. No statistical significant differences between baseline CCTs (P>0.05 for both devices) in both groups. In both group experimental eyes, neither SP-3000P nor USP-measured CCTs varied significantly from the control eyes at 5 (P>0.05) and 10 (P>0.05) mins postinstillation of drops in both sessions. In group one, the 95% confidence intervals (CIs) for the SP-3000P CCTs were similar at 5 (-16 to 17 μm) and 10 min (-16 to 17 μm), but in the USP-measured CCTs, it was wider at 10 min (-41 to 46 μm) than at 5 min (-30 to 41 μm) postinstillation. In group two, the 95% CIs at 5 and 10 mins postinstillation, respectively, ranged between -20 and 47 μm, -21 and 43 μm (SP-3000P) and -29 and 23 μm, -26 and 23 μm (USP). Within groups and between groups, variations in CCT were similar at both times intervals in all comparisons.
  
  
  CONCLUSIONS
  Although oxybuprocaine HCl and thera tears consistently did not affect the mean CCT obtained by both devices at both time intervals, variation in SP-3000P measured CCT was more consistent in both sessions and narrower in relation to USP-measured CCT. It may be reasonable to suggest that measurements of CCT in normal patients be taken before examinations requiring instillation of anesthetics or such measurements when obtained postinstillation of either oxybuprocaine or preserved artificial tears be interpreted with caution.
authors: Corneal Research Chair, Department of Optometry and Vision Sciences, College of Applied Medical Sciences, King Saud University, Riyadh, Kingdom of Saudi Arabia.
authors: Turki M
authors: TM
authors: Almubrad
authors: Fayez H
authors: FH
authors: Alshehri
authors: Kelechi C
authors: KC
authors: Ogbuehi
authors: Uchechukwu L
authors: UL
authors: Osuagwu
mesh_terms: D060433:Administration, Ophthalmic; D000328:Adult; D002266:Carboxymethylcellulose Sodium / Q000494:pharmacology; D003315:Cornea / Q000187:drug effects* / Q000378:metabolism; D063171:Corneal Pachymetry / Q000379:methods; D005260:Female; D006801:Humans; D008297:Male; D009883:Ophthalmic Solutions / Q000494:pharmacology*; D011310:Preservatives, Pharmaceutical / Q000737:chemistry; D011343:Procaine / Q000031:analogs & derivatives* / Q000494:pharmacology; D011446:Prospective Studies; D013997:Time Factors; D055815:Young Adult
chemical_list: D009883:Ophthalmic Solutions; D011310:Preservatives, Pharmaceutical; D011343:Procaine; C005298:benoxinate; D002266:Carboxymethylcellulose Sodium